Penn Medicine Advanced Multimodality Cardiac Imaging Symposium 2024

Overview

The Penn Medicine Advanced Multimodality Cardiac Imaging Symposium 2024 provides a comprehensive exploration of the latest advances and applications in advanced cardiac imaging. This symposium covers critical topics including valvular heart diseases, aortopathies, cardiomyopathies, genetic heart diseases, coronary artery disease, and arrhythmias, emphasizing practical imaging approaches for diagnosis and management. On-demand cardiology education — accessible anytime, anywhere.

Format: 43 videos and 51 PDFs
Total size: 8.11 GB

Agenda

This symposium delivers expert presentations and case-based discussions addressing multimodality cardiac imaging techniques and their clinical applications. Key topics include echocardiography, cardiac MRI, computed tomography, nuclear imaging, and artificial intelligence in cardiac imaging.

• Advantages and Disadvantages of Functional Stress Testing in the Assessment of Chest Pain in the ED
• Advocacy and Cardiovascular Imaging – You Need a Seat at the Table!
• Approach to Cardiac Amyloidosis – Screening and Diagnostic Workflow
• Approach to Undifferentiated Chest Pain in the ED
• Artificial Intelligence in Multimodality Cardiac Imaging
• Asymptomatic High-Risk Patients
• Case Presentations: Amyloidosis, Complex Coronary Artery Disease, Sarcoidosis, Aortic Valve, Mitral Valve, Tricuspid Valve, and Special Populations
• Case Review of Patients with Hypertrophic Cardiomyopathy
• Chest Pain Evaluation in the High Sensitivity Troponin Era
• Chest Pain or Myocardial Ischemia in Patients With Non-Obstructive Coronary Arteries
• Clinical Scenarios to Consider Viability Assessment
• CMR in Patients with Ventricular Arrhythmias
• Diagnosing Hypertrophic Cardiomyopathy and Differentiation from Phenocopies
• Diagnosis and Management of Cardiac Sarcoidosis
• Evaluation of Chest Pain in Patients with Cardiomyopathies
• Imaging Considerations for Aortic, Mitral, and Tricuspid Valve Interventions; Watchman Implantation
• Imaging Features of Cardiac MRI and PET Scanning for Diagnosis, Prognosis, and Treatment Response
• Imaging of Genetic Arrhythmogenic Cardiomyopathies
• Imaging of Native and Prosthetic Valve Dysfunction and Infections
• Multimodality Imaging in the Evaluation of Syncope
• New Treatments in Hypertrophic Cardiomyopathy and Monitoring Response
• Nuclear Protocols and Diagnostic Challenges
• Overview of Echocardiography and Cardiac MRI Features of Cardiac Amyloidosis
• Panel Discussions and Q&A Sessions on Chest Pain Evaluation and Coronary Artery Disease
• Patients with Anomalous Coronary Arteries
• Risk Stratification of Patients With Hypertrophic Cardiomyopathy
• Role of Coronary CT with FFR
• SPECT vs PET Imaging Modalities
• Surgical Perspectives on Aortopathies
• Updates and Controversies on Bicuspid Valve Disease
• Using Imaging to Guide Septal Reduction Therapies
• When and How to Use PET Scanning
• When and When Not to Use Coronary CT as Initial Test for Chest Pain in the ED
• When to Consider Echocardiography
• Role and Benefits of Stress Cardiac MRI

Learning Objectives

After completing this activity, participants should be able to:

• Review the role of advanced imaging in the diagnosis of native valve disease, prosthetic valve disease, and aortopathies
• Discuss the application of echocardiography and computed tomography in transcatheter valve therapies
• Describe the role of echocardiography, cardiac MRI, and nuclear imaging in diagnosing cardiac amyloidosis, including diagnostic challenges
• Review the complementary role of nuclear imaging and cardiac MRI in diagnosing and monitoring cardiac sarcoidosis
• Describe imaging features of hypertrophic cardiomyopathy and its phenocopies
• Explain the role of cardiac MRI in risk stratification of hypertrophic cardiomyopathy patients
• Discuss advanced cardiac imaging to guide septal reduction therapies and monitor novel treatments in hypertrophic cardiomyopathy
• Review noninvasive cardiac imaging for evaluation of suspected or confirmed coronary artery disease and viability assessment
• Discuss the role of echocardiography, cardiac CT, and cardiac MRI in the assessment and management of atrial and ventricular arrhythmias

Speakers

This symposium features presentations and discussions led by subject matter experts in advanced multimodality cardiac imaging, cardiology, and radiology. The content reflects current academic and clinical perspectives in advanced cardiac diagnostic techniques.

Target Audience

This activity is designed for healthcare professionals in cardiology, internal medicine (including subspecialties such as advanced heart failure, transplant cardiology, cardiovascular disease, clinical cardiac electrophysiology, interventional cardiology), family medicine, and radiology (including nuclear radiology). It is suitable for physicians, nurses, nurse practitioners, and physician assistants involved in cardiac patient care.

Why This Topic Matters

The Penn Medicine Advanced Multimodality Cardiac Imaging Symposium 2024 addresses the critical need for comprehensive understanding and application of advanced cardiac imaging modalities. Multimodality imaging plays an essential role in diagnosing and managing complex cardiac conditions across multiple specialties in cardiovascular medicine.

Access to this symposium via MedHub Central supports clinicians in strengthening their expertise and confidence in interpreting imaging data, ultimately enhancing patient care through informed clinical decision-making. This resource is valuable for professionals seeking to deepen knowledge in current and emerging cardiac imaging strategies.